Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease

Worldwide, approximately 27 million people are affected by Alzheimer’s disease (AD). AD pathophysiology is believed to be caused by the deposition of the β-amyloid peptide (Aβ). Aβ can reduce long-term potentiation (LTP), a form of synaptic plasticity that is closely associated with learning and mem...

Descripción completa

Detalles Bibliográficos
Autores principales: Leo, Damiana, Targa, Giorgia, Espinoza, Stefano, Villers, Agnès, Gainetdinov, Raul R., Ris, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318502/
https://www.ncbi.nlm.nih.gov/pubmed/35887159
http://dx.doi.org/10.3390/ijms23147811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318502/
https://www.ncbi.nlm.nih.gov/pubmed/35887159
http://dx.doi.org/10.3390/ijms23147811

Ejemplares similares